Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 June, 2019 21:03 IST
Strides Pharma Science receives EIR for Bangalore unit
Source: IRIS | 06 Feb, 2019, 11.44AM
Comments  |  Post Comment

Strides Pharma Science announced that its formulations facility (KRSG Gardens) in Bangalore which was inspected by the USFDA in August 2018 and November 2018, has received the Establishment Inspection Report (EIR), there by confirming the successful closure of the inspections. The inspection conducted in November 2018 had concluded with Zero 483 observations.

The flagship facility in Bangalore manufacturers tablets, capsules, liquids, creams ointments, sachets. The facility is the largest for company and supports several current and future products for the US markets.

Shares of the company declined Rs 10.1, or 2.4%, to trade at Rs 410.95. The total volume of shares traded was 97,058 at the BSE (10.46 a.m., Wednesday).



Strides Pharma Science Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer